Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06074133 · ClinicalTrials.gov registry record
A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules
A clinical trial of Pulmonary Nodule, sponsored by Vanderbilt-Ingram Cancer Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 4
- Study locations
NCT06074133 is a study of Pulmonary Nodule that is actively recruiting participants, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 100 participants, below the 338-participant average among 4 other Pulmonary Nodule trials with a reported enrollment target (70% lower). The trial reports 4 study locations across 2 states.
The verdict
NCT06074133, a study of Pulmonary Nodule, is actively recruiting participants, sponsored by Vanderbilt-Ingram Cancer Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.
Conditions Studied
Interventions
- PROCEDURE Blood collection
- PROCEDURE Chest Computed Tomography
Study Locations (4)
Colorado
- Rocky Mountain Regional VA Medical Center - Aurora
- University of Colorado - Aurora
Tennessee
- Vanderbilt University/Ingram Cancer Center - Nashville
- VA Tennessee Valley Healthcare Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-03-07 |
| Est. Completion | 2029-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06074133
The ClinicalTrials.gov registry entry for NCT06074133 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 338-participant average among 4 other Pulmonary Nodule trials with a reported enrollment target (70% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Nodule appearing as the primary indexed condition, and to 2 interventions - of which Blood collection is the first listed.
NCT06074133 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06074133 about?
NCT06074133 is a clinical study titled "A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules". This is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.
What is the current status of trial NCT06074133?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-03-07. Estimated completion is 2029-03-31.
What conditions does trial NCT06074133 study?
This clinical trial studies the following conditions: Pulmonary Nodule.
What interventions are being tested in trial NCT06074133?
The interventions under investigation include: Blood collection (PROCEDURE), Chest Computed Tomography (PROCEDURE).
Who is sponsoring clinical trial NCT06074133?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06074133 being conducted?
This trial has 4 study locations across Colorado, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Nodule
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Utility for Ion Endoluminal System
ACTIVE NOT RECRUITING · NA
-
Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung
COMPLETED
-
A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions
COMPLETED
-
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.